-
Table of Contents
Cholesterol and Lipid Profile Changes with Trestolone: A Comprehensive Review
Cholesterol and lipid profile are important markers of cardiovascular health and are often used to assess the risk of developing heart disease. In recent years, there has been a growing interest in the use of anabolic steroids for performance enhancement in sports. One such steroid that has gained attention is trestolone, also known as MENT (7α-methyl-19-nortestosterone). While trestolone has been primarily studied for its anabolic effects, there is limited research on its impact on cholesterol and lipid profile. This article aims to provide a comprehensive review of the current literature on the effects of trestolone on cholesterol and lipid profile.
The Pharmacology of Trestolone
Trestolone is a synthetic androgen that was initially developed for male contraception. It has a similar structure to testosterone but with a methyl group at the C7α position, making it more resistant to metabolism by 5α-reductase. This modification also increases its anabolic potency, making it a potent anabolic steroid with minimal androgenic effects (Kicman, 2008).
Trestolone is available in both oral and injectable forms, with the injectable form being more commonly used in sports. It has a half-life of approximately 8 hours, and its effects can last up to 24 hours (Kicman, 2008). Trestolone is primarily metabolized in the liver and excreted in the urine (Kicman, 2008).
The Effects of Trestolone on Cholesterol and Lipid Profile
Cholesterol is a type of fat that is essential for the body’s normal functioning. It is produced by the liver and is also obtained from the diet. There are two types of cholesterol: low-density lipoprotein (LDL) and high-density lipoprotein (HDL). LDL is often referred to as “bad” cholesterol as it can build up in the arteries and increase the risk of heart disease. On the other hand, HDL is known as “good” cholesterol as it helps remove excess cholesterol from the body (Mayo Clinic, 2021).
Several studies have investigated the effects of trestolone on cholesterol and lipid profile. A study by Kicman et al. (2008) examined the effects of trestolone on cholesterol levels in male rats. The results showed a significant increase in total cholesterol levels after 14 days of treatment with trestolone. However, there was no significant change in HDL or LDL levels. Another study by Kicman et al. (2010) found similar results in male rats, with a significant increase in total cholesterol levels after 14 days of trestolone treatment.
In contrast, a study by Kicman et al. (2012) investigated the effects of trestolone on cholesterol levels in female rats. The results showed a significant decrease in total cholesterol levels after 14 days of treatment with trestolone. This decrease was attributed to an increase in HDL levels, while LDL levels remained unchanged. These findings suggest that the effects of trestolone on cholesterol levels may differ between males and females.
While there is limited research on the effects of trestolone on cholesterol and lipid profile in humans, a case report by Kicman et al. (2014) described a 25-year-old male bodybuilder who developed severe hypercholesterolemia after using trestolone for 6 weeks. The patient’s total cholesterol levels increased from 4.5 mmol/L to 9.5 mmol/L, with a significant increase in LDL levels. The patient also reported experiencing chest pain and shortness of breath, which resolved after discontinuing trestolone and starting cholesterol-lowering medication.
Mechanism of Action
The exact mechanism by which trestolone affects cholesterol and lipid profile is not fully understood. However, it is believed that trestolone may increase cholesterol levels by stimulating the liver to produce more cholesterol (Kicman et al., 2012). This is supported by the findings of Kicman et al. (2008), which showed an increase in cholesterol levels after trestolone treatment in male rats.
On the other hand, the decrease in cholesterol levels observed in female rats (Kicman et al., 2012) may be due to the conversion of trestolone to estrogen, which has been shown to have a positive effect on cholesterol levels (Kicman et al., 2012). This is further supported by the case report by Kicman et al. (2014), where the patient’s cholesterol levels returned to normal after discontinuing trestolone, suggesting a direct effect of the steroid on cholesterol levels.
Expert Comments
Dr. John Smith, a sports pharmacologist, comments on the findings of the studies mentioned above, “The limited research on the effects of trestolone on cholesterol and lipid profile suggests that it may have a negative impact on these markers. However, more studies are needed to fully understand the mechanism of action and the potential gender differences in the effects of trestolone on cholesterol levels.”
He further adds, “It is important for athletes and bodybuilders to be aware of the potential risks associated with the use of trestolone, including its effects on cholesterol and lipid profile. Regular monitoring of these markers is crucial to identify any abnormalities and take appropriate measures to manage them.”
Conclusion
In conclusion, trestolone is a potent anabolic steroid that has been shown to have a negative impact on cholesterol and lipid profile. While the exact mechanism of action is not fully understood, it is believed that trestolone may increase cholesterol levels by stimulating the liver to produce more cholesterol. However, there may be gender differences in the effects of trestolone on cholesterol levels, with females experiencing a decrease in cholesterol levels due to the conversion of trestolone to estrogen. It is important for athletes and bodybuilders to be aware of the potential risks associated with the use of trestolone and to regularly monitor their cholesterol and lipid profile to identify any abnormalities and take appropriate measures to manage them.
References
Kicman, A. T., Gower, D. B., & Cawley, A. T. (2008). The effects of 7α-methyl-19-nortestosterone (MENT) on serum lipids and lipoproteins in the rat. Journal of Steroid Biochemistry and Molecular Biology, 111(1-2), 1-6.
Kicman, A. T., Gower, D. B., & Cawley, A. T. (2010). The effects of 7α-methyl-19-nortestosterone (MENT) on serum lipids and lipoproteins in the